GLP1R and type 2 diabetes mellitus: GLP-1 receptor agonists (GLP-1RAs) are used widely in the management of type 2 diabetes, and increasingly in obesity, and can be classified as either ‘short-’ or ‘long-acting’ based on their plasma half-lives.